View in EDS

Zanubrutinib in B-cell lymphomas: from clinical pharmacology to therapeutic application.

Saved in:
Bibliographic Details
Title: Zanubrutinib in B-cell lymphomas: from clinical pharmacology to therapeutic application.
Authors: Chen TB; Research Division of Clinical Pharmacology, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.; School of Pharmacy, Nanjing Medical University, Nanjing, 211166, China.; Department of Pharmacy, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, 214071, China., Yan YT; Research Division of Clinical Pharmacology, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China., Sun LN; Research Division of Clinical Pharmacology, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.; School of Pharmacy, Nanjing Medical University, Nanjing, 211166, China., Guo YJ; Research Division of Clinical Pharmacology, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. 279718730@qq.com., Wang YQ; Research Division of Clinical Pharmacology, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. wyqjsph@163.com.; School of Pharmacy, Nanjing Medical University, Nanjing, 211166, China. wyqjsph@163.com.
Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2026 Jan 19; Vol. 82 (2), pp. 54. Date of Electronic Publication: 2026 Jan 19.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-1041
DOI:10.1007/s00228-025-03987-4